Susan Moench, PhD, PA-C

Oncology Writer

Susan Moench has been working as a medical writer since 2003. Prior to joining the staff of Cancer Therapy Advisor and Oncology Nurse Advisor as an oncology writer, she spent approximately 4 years as a medical writer at the Rutgers Cancer Institute of New Jersey, where she collaborated with oncologists on clinical trial protocols and publications related to precision oncology. Previous positions included approximately 5 years as an oncology scientist/senior medical writer at the National Comprehensive Cancer Network (NCCN), where she contributed to the development and update of clinical practice guidelines covering the diagnosis and treatment of a broad range of malignancies as well as supportive care issues in cancer. Susan received her PhD in Biochemistry from Colorado State University; she also holds an MS in Physician Assistant studies from DeSales University and is a certified physician assistant.

All articles by Susan Moench, PhD, PA-C

Disease Recurrence Risk for Patients With Rectal Cancer Followed With “Watch and Wait”

The “watch and wait” approach is characterized by close surveillance without surgery in patients with rectal cancer who achieve a clinical CR following neoadjuvant CRT.

Susan Moench, PhD, PA-C

December 30, 2020

Adverse Event Management

Prevalence of Insomnia Syndrome Found to Be High in Patients With Cancer

Using a self-report questionnaire, investigators sought to distinct insomnia syndrome distinct from sleep disturbance in patients with cancer.

Susan Moench, PhD, PA-C

December 28, 2020

Hematologic Cancers

Comparison of Systemic Therapies for MPN Subtypes in the Real-World Setting

In this prospective study, the efficacy and safety of conventional therapy, pegylated interferon alpha-2a, and ruxolitinib in the treatment of MPNs were compared.

Susan Moench, PhD, PA-C

December 23, 2020

Adverse Event Management

Addition to Supportive Care Documentation Decreased AE Risks Associated With High-Dose Methotrexate

Incorporating 2 standardized documents into the process for supportive care measures improved outcomes for patients receiving HD-MTX.

Susan Moench, PhD, PA-C

December 21, 2020

Genitourinary Cancers

Papillary RCC Subtype Not Predictive of Survival, Study Finds

Two subtypes of papillary RCC – type I and type II – have been previously described.

Susan Moench, PhD, PA-C

December 21, 2020

Topics in Clinician-Patient Conversations Expand With Telehealth-Based Palliative Care

Researchers describe the experiences of a telemedicine-based palliative care clinic at a large academic cancer center.

Susan Moench, PhD, PA-C

December 18, 2020

Adverse Event Management

Distinguishing Neutropenia From Pseudoneutropenia Can Preserve Antineoplastic Therapy

Retrospective analysis demonstrates the value in distinguishing between these conditions to salvage chemotherapy and/or targeted therapy dose in patients with cancer.

Susan Moench, PhD, PA-C

December 16, 2020

Residential Region, Lifestyle Associated With Increased Mortality in Women With Early-Onset CRC

Incidence of early-onset CRC found more prevalent in some US regions referred to as “hot spots.”

Susan Moench, PhD, PA-C

December 14, 2020

Pilot Program Demonstrates Feasibility of an Oral Oncology Drug Repository Program

Best practices and challenges encountered in implementing a repository program for oral oncology drugs at a large cancer center.

Susan Moench, PhD, PA-C

December 11, 2020

AI-Based Model Made Optimal Selections of Frontline TKI Therapy in CML

Investigators report on outcomes for patients with chronic phase CML whose treatment was determined using an artificial intelligence-based model.

Susan Moench, PhD, PA-C

December 9, 2020